- Category
- Micro (2022-23)
- Udyam number
- UDYAM-OD-24-0004145

Define Pharmaceuticals Private Limited
About Define Pharmaceuticals Private Limited
Data last updated:
Define Pharmaceuticals Private Limited is a private limited company based in Ranpur, Odisha, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 23 May 2022.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51909OR2022PTC039801.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanyasi Pradhan (Managing Director) and Jyotirmayee Pati.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Satyabhama Pradhan Beguniapatana Po Khatia Ps Sarankula, Ranpur, Odisha, India – 752079.
As per the financials filed for FY 2026, the company reported a revenue of ₹5 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹14,827 (net margin 3%) and EBITDA of ₹49,319 (EBITDA margin 9.9%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
Define Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-24-0004145).
Company details
Recognitions & Rankings of Define Pharmaceuticals
Contact details
Define Pharmaceuticals Private Limited's registered office is in Ranpur, Odisha.
- Registered AddressC/O Satyabhama Pradhan Beguniapatana Po Khatia Ps Sarankula, Ranpur, Odisha, India – 752079
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Define Pharmaceuticals Private Limited
FY 2025 filings availableDefine Pharmaceuticals Private Limited reported revenue of ₹5 Lakh (down 23% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue fell 23% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 19%. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹49,319 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹14,827 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 9.9% | |||
| Net Profit Margin | 3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Define Pharmaceuticals Private Limited, buy the company report.
Board of directors of Define Pharmaceuticals Private Limited
Define Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanyasi Pradhan Also directs: Dmploi Tech Private Limited | Managing Director | 23 May 2022 | 4 Years 5 Months | Current |
| Jyotirmayee Pati | Director | 23 May 2022 | 4 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Define Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Define Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Define Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Define Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Jyotirmayee Pati was appointed as Director on 23 May 2022.
Frequently asked questions
Define Pharmaceuticals is an active private limited company based in Ranpur, Odisha, India. The company works in specialty, within the trading industry. It was incorporated on 23 May 2022 (4+ years old) and is registered under CIN U51909OR2022PTC039801.
Define Pharmaceuticals has 2 current directors:
- Sanyasi Pradhan - Managing Director
- Jyotirmayee Pati - Director
The latest financial statements of Define Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Define Pharmaceuticals is U51909OR2022PTC039801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Define Pharmaceuticals was incorporated on 23 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Cuttack.
Jyotirmayee Pati was appointed as Director on 23 May 2022. Sanyasi Pradhan was appointed as Managing Director on 23 May 2022.
Yes, Define Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-24-0004145).
The registered office of Define Pharmaceuticals is at CO Satyabhama Pradhan Beguniapatana Po Khatia Ps Sarankula, Ranpur, Odisha, India – 752079.
Define Pharmaceuticals operates in the trading industry, in the specialty segment.
Define Pharmaceuticals can be reached at its registered office: CO Satyabhama Pradhan Beguniapatana Po Khatia Ps Sarankula, Ranpur, Odisha, India – 752079.